GetTopicDetailResponse(id=c33a8084dd, topicName=GLP-1激動劑semaglutide, introduction=GLP-1激動劑semaglutide, content=null, image=null, comments=1, allHits=1092, url=https://h5.medsci.cn/topic?id=8084, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=103240, tagList=[TagDto(tagId=103240, tagName=GLP-1激動劑semaglutide)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1778402, encodeId=b79d1e7840202, content=<a href='/topic/show?id=c33a8084dd' target=_blank style='color:#2F92EE;'>#GLP-1激動劑semaglutide#</a>, objectTitle=諾和諾德的GLP-1激動劑semaglutide：非酒精性脂肪性肝炎的II期臨床展現(xiàn)治療潛力, objectType=article, longId=193810, objectId=97c7193810df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97c7193810df, replyNumber=0, likeNumber=104, createdTime=2020-09-02, rootId=0, userName=lishizhe, userId=c15839191762, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97c7193810df, moduleTitle=諾和諾德的GLP-1激動劑semaglutide：非酒精性脂肪性肝炎的II期臨床展現(xiàn)治療潛力, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=97c7193810df)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
